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atrix Gla protein (MGP) is a 14-kD extracellular
matrix protein of the mineral-binding Gla protein
family. Studies of MGP-deﬁcient mice suggest that
MGP is an inhibitor of extracellular matrix calciﬁcation in
 
arteries and the epiphyseal growth plate. In the mammalian
growth plate, MGP is expressed by proliferative and late
hypertrophic chondrocytes, but not by the intervening
chondrocytes. To investigate the functional signiﬁcance of
 
this biphasic expression pattern, we used the ATDC5 mouse
chondrogenic cell line. We found that after induction of the
 
cell line with insulin, the differentiating chondrocytes ex-
press MGP in a stage-speciﬁc biphasic manner as in vivo.
Treatment of the ATDC5 cultures with MGP antiserum
M
 
during the proliferative phase leads to their apoptosis before
maturation, whereas treatment during the hypertrophic
phase has no effect on chondrocyte viability or mineraliza-
tion. After stable transfection of ATDC5 cells with inducible
sense or antisense MGP cDNA constructs, we found that
 
overexpression of MGP in maturing chondrocytes and un-
derexpression of MGP in proliferative and hypertrophic
chondrocytes induced apoptosis. However, overexpression
of MGP during the hypertrophic phase has no effect on
chondrocyte viability, but it does reduce mineralization. This
work suggests that coordinated levels of MGP are required
for chondrocyte differentiation and matrix mineralization.
 
Introduction
 
Matrix Gla protein (MGP)* is a 14-kD member of the mineral-
binding Gla protein family (Price and Williamson, 1985),
which includes a number of coagulation factors, osteocalcin,
and the growth arrest–specific protein 6 (Gas6). MGP binds
calcium ions and hydroxyapatite via its five 
 
 
 
-carboxylated
 
glutamic acid (Gla) residues. The MGP gene is widely ex-
pressed, but the protein only accumulates significantly in
bone, cartilage, and dentin (Hale et al., 1988). Within the
mammalian growth plate during endochondral bone forma-
tion, MGP gene expression is confined to the proliferative
and late hypertrophic chondrocytes, but is absent in the ma-
turing/early hypertrophic chondrocytes (Luo et al., 1995).
The MGP-deficient mouse is characterized by aberrant ar-
terial and cartilage calcification, providing compelling evi-
dence that MGP is an important inhibitor of extracellular
matrix mineralization in these tissues (Luo et al., 1997). Fur-
ther, inhibition of the 
 
 
 
-carboxylation of Gla residues with
warfarin in both cell culture and in vivo results in increased
matrix mineralization, suggesting that the mineral-binding
Gla residues of proteins such as MGP are crucial for the regu-
lation of matrix mineralization (Price et al., 1998; Yagami et
al., 1999). In addition, the rare autosomal recessive condition
Keutel syndrome, in which patients are affected by aberrant
cartilage calcification, has been shown to be due to mutations
in the gene encoding MGP (Munroe et al., 1999).
As well as a role in matrix calcification, it has been pro-
posed that MGP may have additional functions. Evidence in
support of this hypothesis includes the arteries in the MGP-
deficient mouse undergoing chondrocyte metaplasia, which
indicates that MGP may have a role in cellular differentia-
tion (Luo et al., 1997). Further, the epiphyseal growth plate
is disorganized in the MGP-deficient mouse (Luo et al.,
1997), in that the proliferative chondrocytes fail to form reg-
ular palisaded columns and hypertrophic chondrocytes are
absent. In this situation, it is unclear whether the aberrant
calcification causes disruption of the normal proliferative
chondrocyte zone architecture, or if MGP has a direct influ-
ence on chondrocyte maturation. However, misexpression
of MGP in chick embryo limb buds has been shown to in-
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hibit the formation of hypertrophic chondrocytes during en-
dochondral bone growth (Yagami et al., 1999). Altered
MGP gene expression has also been demonstrated in a vari-
ety of metastatic cancers and tumor cell lines (Chen et al.,
1990; Levedakou et al., 1992; Clark et al., 2000).
To explore the functions of MGP during chondrocyte dif-
ferentiation, we have used the mouse chondrogenic cell line
ATDC5. This cell line has been extensively characterized and
shown to be an elegant model to study gene expression and
phenotypic changes during normal endochondral ossification
(Atsumi et al., 1990; Shukunami et al., 1996, 1997). With
insulin supplementation, the ATDC5 cells rapidly proliferate
to form a confluent cell monolayer. After 7 d of culture, the
cells form discrete condensations and express type II collagen
(Atsumi et al., 1990). The condensations differentiate to
form cartilage nodules and type X collagen, a marker of
chondrocyte hypertrophy (Reichenberger et al., 1991), is ex-
pressed by day 15. At day 21, the medium is supplemented
with ascorbic acid and the carbon dioxide levels are reduced
to encourage calcification of the matrix in the absence of
 
 
 
-glycerophosphate via a matrix vesicle–mediated mechanism.
This is evident from day 30 onwards (Shukunami et al.,
1997). This cell culture system has enabled us to examine the
effects of both over- and underexpression of MGP at specific
stages of chondrocyte differentiation. Our findings have
identified that coordinately regulated levels of MGP during
chondrocyte differentiation are crucial for chondrocyte sur-
vival. In addition, we have confirmed a role for MGP in reg-
ulating mineralization of hypertrophic chondrocytes.
 
Results
 
Gene expression and characterization of ATDC5 cells
 
The ATDC5 cells proliferated rapidly in insulin-supple-
mented medium after plating out and attained confluence
by day 5. Condensation of cells was evident by day 9 and
cartilage nodule formation by day 15. After alteration of cul-
ture conditions, calcification of the matrix could be detected
by day 32, and by day 42 a significant proportion of the cul-
ture was stained positively with alizarin red. These morpho-
logical changes are consistent with the stepwise differentia-
tion described previously (Atsumi et al., 1990; Shukunami
et al., 1997).
Gene expression at various time points was assessed by
northern analysis to compare patterns with previous studies
and to determine the expression pattern of MGP (Fig. 1).
Expression was analyzed at five time points during ATDC5
differentiation: confluent cultures (day 5), chondrocyte con-
densation (day 9), cartilage nodule formation (day 15), evi-
dence of chondrocyte hypertrophy (day 21), and matrix
mineralization (day 32). We identified expression of type II
collagen from day 9 onwards, concomitant with the chon-
drocytes becoming elongated and forming recognizable cel-
lular condensations. Type X collagen gene expression was
detectable at day 15 and increased at day 21 as the chondro-
cytes were maturing to hypertrophy. MGP expression was
detectable at low levels at day 9, but significantly present at
day 15. These results are comparable with those of previous
studies (Shukunami et al., 1996; Thomas et al., 2000). The
 
level of MGP was lower at day 21, but increased again at day
32. This mirrors the biphasic (on-off-on) expression pattern
described in the growth plate (Luo et al., 1995). Expression
of the osteoblast-specific protein, osteocalcin, was detectable
at day 32, consistent with previous work (Akiyama et al.,
1999) suggesting that the ATDC5 cells attain an osteoblas-
tic phenotype.
 
Treatment of ATDC5 cultures with MGP antisera
 
To establish the effects of manipulating MGP in ATDC5
cells, we treated cultures with an antiserum to MGP. We
confirmed the specificity of the antiserum raised to a peptide
corresponding to the COOH-terminal region of mouse
MGP by both Western analysis (Fig. 2) and immunohis-
tochemical analysis of bovine fetal growth plates, which
showed staining of proliferative and hypertrophic chondro-
cytes, but not the intervening maturing chondrocytes (re-
sults not shown). The ATDC5 cells were treated with the
antiserum from either day 3 or from day 21 and at each sub-
sequent medium change. The cells treated with the antise-
rum from day 3 began to condense and grew normally until
day 10, when the cells detached from the culture dishes (Fig.
3), whereas control cultures treated with normal rabbit se-
rum differentiated normally through to matrix mineraliza-
tion. To determine whether the cells in the antibody-treated
cultures were dying by apoptosis, we trypsinized the adher-
ent cells and fixed them in formaldehyde before staining
with Hoescht 33258. Analysis under ultraviolet light re-
vealed that the MGP antiserum–treated chondrocytes had
typical apoptotic morphology with nuclei that were frag-
mented and condensed (Fig. 4). The chondrocytes treated
with rabbit serum showed no alteration. To confirm these
findings, we established the expression levels of 
 
bcl-2
 
 in both
the antiserum-treated and control ATDC5 cells. Bcl-2 is a
member of a family of apoptosis regulatory gene products
and specifically acts as an antagonist of the effector stage of
apoptosis (Kroemer, 1997). In the antiserum-treated cul-
tures, levels of expression of 
 
bcl-2
 
 were significantly higher
(
 
P
 
 
 
 
 
 0.02) than in the control cultures at the time point im-
mediately before chondrocyte detachment (Fig. 5). In addi-
tion, the 
 
bcl-2:bax
 
 ratio was threefold greater in the control
cultures compared with the antiserum-treated cultures at the
same time point. This suggests that the antiserum-treated
chondrocytes were dying due to apoptosis. Real time PCR
analysis of type II collagen revealed no significant difference
between antiserum-treated and control cultures (Fig. 5),
supporting the specific effect of the antiserum and confirm-
ing that the cultures were similarly differentiated. In addi-
tion, levels of MGP transcripts were decreased in the antise-
rum-related cultures just before chondrocyte apoptosis (Fig.
5). This suggests that one of the effects of the antiserum in-
teraction with MGP was to lower transcription of MGP at
this stage of chondrocyte differentiation. MGP transcription
is potentially influenced in a feedback mechanism depen-
dent on the MGP in the chondrocytes’ environment.
The cells treated with the antiserum from day 21 grew nor-
mally until day 42 and there was no statistical difference in the
degree of matrix mineralization in the treated and control cul-
tures by measurement of calcium levels (
 
P 
 
 
 
 0.59; Fig. 6). 
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Inducible inhibition of MGP expression 
by antisense transcripts in ATDC5 cells
 
To determine the effects of decreased levels of MGP at vari-
ous stages of chondrocyte differentiation, we adopted an an-
tisense RNA approach. We constructed an ecdysone-induc-
ible plasmid (pIND) which contained a 416-bp fragment of
mouse MGP cDNA subcloned into the EcoR1 and BamH1
sites of the pIND multiple cloning site in the antisense (3
 
 
 
to 5
 
 
 
) orientation under the transcriptional control of the
ecdysone responsive promoter. After dual transfection of
ATDC5 cells with the pIND antisense construct (pINDE/
B) and pVgRXR, cells were selected in G418 and Zeocin-
containing medium for 14 d. Six stably transfected clones
were picked by ring cloning and expanded.
Clone E/B2, which expressed the inducible antisense
MGP cDNA, was selected and plated out in multiple 6-well
plates. From day 3, 5 
 
 
 
M ponasterone A was added to the
medium at each medium change. After induction with pon-
asterone A, total RNA was extracted from the induced and
Figure 1. Expression of cartilage and bone markers during ATDC5 
cell differentiation. Northern blot analysis was performed on 20  g 
of total RNA extracted from ATDC5 cell cultures on day 5 (conflu-
ence), day 9 (condensation), day 15 (nodule formation), day 21 
(maturation), and day 32 (chondrocyte hypertrophy and matrix 
mineralization). Filters were serially hybridized with murine cDNA 
probes for type II collagen, type X collagen, osteocalcin, MGP, and 
 -actin. Transcript sizes are indicated on the left.
Figure 2. Confirmation of inducible expression by RT-PCR and 
Western blotting. (A) Detection of inducible cDNA transcripts by 
RT-PCR from ATDC5 cultures transfected with pINDE/X (sense 
construct) or transfected with pINDE/B (antisense construct, 
AS-MGP) and induced with ponasterone A from day 3 of culture or 
noninduced as a control. Total RNA was extracted at day 7 of cell 
culture and the RT-cDNA was amplified by PCR for 23 cycles. 
Aliquots (5  l) of the PCR products were resolved on 1.5% (wt/vol) 
agarose gels alongside molecular weight markers (M). Lane 1, clone 
E/X 3 induced; lane 2, clone E/X3 noninduced; lane 3, clone E/X 5 
induced; lane 4, clone E/X5 noninduced; lane 5, control; lane 6, 
clone E/B2 induced; lane 7, clone E/B2 noninduced; lane 8, clone 
E/B6 induced; lane 9, clone E/B6 noninduced. The primers used for 
the target sequences were the ecdysone forward primer and mgpR 
for pINDE/X (to generate a 450-bp fragment and the ecdysone 
forward primer), and mgpF for pINDE/B (to generate a 471-bp 
fragment). (B) Western blot analysis confirming the specificity of the 
MGP antiserum. A single band is identified at  14 kD. In addition, 
different levels of MGP are identified in the transfected compared 
with control cultures. Lane 1, high intensity band corresponding to 
MGP in chondrocytes with overexpressed MGP compared with lane 
2 (control). Lane 3, low intensity band at 14 kD corresponding to 
MGP in sample from cells with induced AS-MGP compared with 
lane 4 (control). Equal loading of protein and efficiency of transfer 
was confirmed by Ponceau S staining. Molecular weight marker 
sizes are indicated on the left.
Figure 3. Cell proliferation of ATDC5 cells treated with MGP 
antiserum. Cell proliferation of ATDC5 cells from day 0–15. Cul-
tures were treated with (a) standard culture conditions (normal), (b) 
normal rabbit serum (nrs) at 1:200 dilution, or (c) antiserum raised 
to a mouse MGP peptide (1:200). Cells supplemented with MGP 
antiserum apoptosed and detached on day 10.
Figure 4. Effects of MGP antiserum on ATDC5 cells. Phase-con-
trast microscopy of ATDC5 cells treated with MGP antiserum after 
10 d of culture. (ai) Control culture treated with normal rabbit serum 
(1:200) from day 3. (aii) Cultures treated with MGP antiserum (1:200) 
from day 3. Cells were stained with Hoescht 33258 to determine 
nuclear morphology of (bi) control culture treated with normal rab-
bit serum and (bii) cultures treated with MGP antiserum showing 
nuclear condensation and fragmentation consistent with apoptosis. 
Bars: (ai and aii) 120  m; (bi and bii) 10  m. 
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noninduced expanded clones and RT-PCR was performed
to confirm inducible expression of the antisense construct
(Fig. 2). Real time PCR analysis confirmed that MGP levels
were reduced in the induced, transfected cells to 
 
 
 
20%
compared with the noninduced cells. The effect of the anti-
sense transcripts was confirmed at the protein level by West-
ern blot analysis (Fig. 2).
The induced transfected cells underwent condensation
and proliferated normally until day 11 (Fig. 7), when they
changed morphology and detached. The detached cells ex-
hibited typical apoptotic morphology, and their DNA was
cleaved into internucleosomal fragments, confirming that
the cell death was by apoptosis (precisely as observed for
the MGP antiserum–treated cultures; Fig. 4). Noninduced,
transfected cell control cultures continued to grow normally.
These results show that suppression of MGP expression at
an early stage of chondrogenesis does not prevent condensa-
tion, but that once cells have condensed the chondrocytes
are unable to mature further to form cartilage nodules.
Expanded E/B2 cells were also induced from day 12 to 26
and day 21 to 26 with ponasterone A to assess the effects of
inhibiting MGP synthesis on ATDC5 cells during their pro-
liferative, maturing, and hypertrophic phases. In both exper-
iments, the chondrocytes grew normally and cartilage nod-
ules formed until day 26, at which stage the cells apoptosed
and detached (results not shown). In contrast, the nonin-
duced cultures grew to 42 d, when normal levels of matrix
mineralization were seen. These findings suggest that MGP
is vital in the hypertrophic phase of ATDC5 culture to
maintain cell survival.
 
Inducible overexpression of MGP in ATDC5 cells
 
To determine the effects of increased levels of MGP at vari-
ous stages of the endochondral ossification pathway, we con-
structed a pIND vector containing a 428-bp fragment of
mouse MGP cDNA subcloned into the EcoR1 and Xba1
sites of the plasmid in-frame in the sense (5
 
 
 
 to 3
 
 
 
) orienta-
tion. After dual transfection of ATDC5 cells with the pIND
sense construct (pINDE/X) and pVgRXR, stably transfected
clones were generated in the same way as for the antisense
clones. Two clones, E/X3 and E/X5, were chosen for further
analysis to confirm stable transfection. Inducible-specific ex-
pression of pINDE/X in the cells was determined by RT-
PCR analysis (Fig. 2).
Clone E/X5, which expressed the inducible sense MGP
cDNA, was plated out in multiple 6-well plates. Cultures
were induced with ponasterone A from day 3 and at each
medium change. Induction with ponasterone A increased
the level of MGP mRNA in the cells, measured by real time
PCR, to 
 
 
 
280% of the level in the noninduced cells. An in-
creased level of expression was confirmed by Western blot
analysis (Fig. 2). The progress of cultures was examined after
induction at day 3 and at day 12. In both instances, the in-
duced cultures grew normally, condensing, proliferating,
and forming cartilage nodules until day 21, when they apop-
tosed and detached (Fig. 8). Noninduced, transfected cell
control cultures continued to grow normally with normal
matrix mineralization at day 42 (Fig. 8). These results sug-
gest that overexpression of MGP has no deleterious effects
on ATDC5 differentiation until day 21. This corresponds to
the time when MGP expression falls, as shown by Northern
analysis (Fig. 1). Real time PCR analysis confirmed raised
MGP levels at multiple time points in the induced, trans-
fected cells compared with their controls. In addition, there
were no significant differences in type II collagen levels be-
tween the induced cells and controls. However, levels of type
X collagen were significantly lower in the transfected cells
(
 
P 
 
 
 
 0.001) compared with the controls. Therefore, the
decrease in MGP levels during the maturing phase of
ATDC5 differentiation is critical to allow chondrocyte pas-
sage through to hypertrophy.
ATDC5 cell cultures transfected with the pINDE/X vec-
tor were also induced at day 21 and thereafter with ponaster-
one A. These cultures grew normally through to day 42 with
maintenance of cartilage nodules. However, alizarin red
staining (Fig. 8) and measurement of calcium levels revealed
marked diminution of matrix mineralization in the induced,
transfected cultures compared with control cultures (
 
P
 
 
 
 
Figure 5. Real time PCR analysis of MGP antiserum–treated 
ATDC5 cells. Real time PCR analysis of levels of (a) MGP tran-
scripts, (b) type II collagen transcripts, and (c) Bcl-2 transcripts in 
ATDC5 cells treated with MGP antiserum or control cultures 
(treated with normal rabbit serum) at different time points. R.Q indi-
cates relative quantitation. The expression levels were normalized 
to  -actin and expressed relative to the levels at day 3, when the 
antiserum was initially added to the cultures. Note lower levels of 
MGP and higher levels of Bcl-2 in the antiserum-treated cultures be-
fore chondrocyte death. The results are shown as the mean and SD 
of four independent determinations.
Figure 6. Calcium levels in MGP antiserum–treated ATDC5 cells. 
Calcium concentrations in ATDC5 cell cultures supplemented with 
MGP antiserum at 1:200 dilution, with normal rabbit serum at 1:200 
dilution, and with no supplements. 
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0.0008; Fig. 9). These findings support previous work which
suggest that MGP functions as a cell-specific inhibitor of
matrix mineralization (Luo et al., 1997; Yagami et al., 1999).
 
Discussion
 
MGP has a biphasic expression pattern 
in the ATDC5 chondrocyte system
 
We used the ATDC5 chondrocyte cell line to examine the
significance of the biphasic expression of MGP within the
mammalian growth plate and to explore whether MGP has
functions beyond that of an inhibitor of matrix mineraliza-
tion in hypertrophic chondrocytes (Luo et al., 1997; Yagami
et al., 1999). The ATDC5 system is ideally suited to such
experimentation, as the chondrocytes undergo a defined pat-
tern of differentiation that resembles that within the mam-
malian growth plate (Shukunami et al., 1996; Enomoto et
al., 2000). Further, we have shown by Northern analysis
that expression is evident in the ATDC5 system MGP at day
9 of culture and increases at day 15 (corresponding to chon-
drocyte proliferation), then decreases at day 21 (correspond-
ing to chondrocyte maturation/onset of hypertrophy), and
increases again at day 32 (corresponding to the onset of ma-
trix mineralization). Thus, the ATDC5 chondrocytes ex-
press MGP in a biphasic manner, similar to that in the
growth plate in vivo (Luo et al., 1995), and thereby provide
a means for examining whether MGP influences critical
stages of the differentiation pathway.
 
Reduction in levels of MGP has an effect on 
proliferative and hypertrophic chondrocyte survival
 
Treatment of cultures with warfarin has previously been used
to examine the role of MGP in chick proliferative and hyper-
trophic chondrocyte cell cultures (Yagami et al., 1999). How-
ever, the effects of warfarin are not specific for MGP, as it can
directly alter the expression of a number of genes normally ex-
pressed in cartilage, as well as inhibit 
 
 
 
-carboxylation of Gla
residues in other Gla-containing proteins apart from MGP
(Barone et al., 1994). To circumvent these problems, we ex-
amined the effects of a reduction in MGP at distinct stages of
differentiation after either treatment of cultures with an anti-
MGP peptide antibody or induction of the expression of an
MGP antisense transcript. We found that treatment of
ATDC5 cultures with the MGP peptide antibody from day 3
of culture did not affect chondrocyte condensation, but in-
duced their apoptosis by day 10 of culture. Inhibition of
MGP expression in the ATDC5 cells by expression of the an-
tisense MGP transcripts over this time period had an identical
effect. These findings suggest that MGP is not required for
chondrocyte condensation despite its abundant expression at a
very early stage in mouse embryonic development in precarti-
lagenous mesenchymal condensations (Luo et al., 1995). This
is in keeping with the findings that in the MGP-deficient
mouse, mesenchymal condensation and subsequent chondro-
cyte formation are not altered (Luo et al., 1997). The induc-
tion of chondrocyte apoptosis by inhibition of MGP in the
ATDC5 cells coincided with the proliferation and cartilage
nodule formation of untreated cultures. A role for MGP in
the survival of chondrocytes at this stage of differentiation
suggests that the disorganization of the proliferative chondro-
cyte zone in the MGP-deficient mouse is not due to aberrant
calcification, but to aberrant chondrocyte proliferation (Luo
et al., 1997). However, our findings contrast with those
demonstrating that warfarin treatment of chick-proliferating
chondrocytes had no adverse effect on their survival or prolif-
eration (Yagami et al., 1999). This suggests that either MGP
is not vital in the chick for proliferative chondrocyte survival,
or that chondrocyte survival is not dependent on the Gla resi-
due, which would be decarboxylated by the warfarin treat-
ment. The fact that the MGP antiserum used in our studies
was raised to a COOH-terminal peptide sequence of MGP
Figure 7. Cell proliferation of ATDC5 cells transfected with MGP 
antisense construct. Cell proliferation of ATDC5 cells transfected 
with pINDE/B. Cultures were induced with 5  M ponasterone A 
from day 3 of culture or not induced. Cells were trypsinized and 
counted on a haemocytometer. At day 11, induced cells apoptosed 
and detached, whereas noninduced cells continued to proliferate 
and differentiate normally with normal matrix mineralization.
Figure 8. Effects of overexpression of MGP in ATDC5 cells. 
ATDC5 cells transfected with pINDE/X after 21 d of culture phase-
contrast microscopy of (ai) noninduced cells and (aii) cells induced 
with 5  M ponasterone A from day 3. Cells stained with Hoescht 
33258 to determine nuclear morphology of (bi) noninduced cells 
and (bii) induced cultures showing nuclear condensation and 
fragmentation consistent with apoptosis. Alizarin red staining on 
day 42 of ATDC5 cells transfected with pINDE/X showing (ci) 
normal mineralization pattern and (cii) after induction from day 21 
with 5  M ponasterone A with reduced mineralization. Bars: (ai and 
aii) 120  m; (bi and bii) 10  m. 
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that does not contain any Gla residues supports this latter hy-
pothesis. Further, the MGP antiserum had no effect on the
mineralization of late stage ATDC5 cells, again suggesting
that the antibody does not alter Gla residue function.
The demonstration that MGP antiserum has the same ef-
fect on chondrocyte survival as expression of the antisense
MGP construct indicates that MGP affects this function at an
extracellular location. The chondrocyte survival properties of
MGP may be mediated via an as yet unidentified cell surface
receptor analogous to the Gas6–Axl tyrosine kinase receptor
interaction. Gas6, another member of the Gla-containing
protein family, is able to protect serum-starved NIH3T3 cells
and vascular smooth muscle cells (VSMC) from undergoing
apoptosis. (Goruppi et al., 1996; Nakano et al., 1996). As in-
hibition of Gas6 activity with anti-Gas6 antibody or warfarin
failed to induce VSMC death, this suggests that the cell sur-
vival properties of Gas6 are not Gla residue–dependent, simi-
lar to the effects noted with MGP (Nakano et al., 1996).
Once the ATDC5 chondrocytes had passed through the
early proliferative phase, inhibition of MGP from either day
12 or 21 had no effect on chondrocyte nodule formation,
but at day 26 (after chondrocyte hypertrophy but before
mineralization) in both instances, the chondrocytes apop-
tosed and detached. This suggests that MGP is vital for hy-
pertrophic chondrocyte survival. The effects of absent MGP
on hypertrophic chondrocytes is not seen in the MGP-defi-
cient mouse as hypertrophic chondrocytes are absent, pre-
sumably as they are unable to mature beyond the prolifera-
tive phase (Luo et al., 1997). In previous studies, warfarin
has been shown to stimulate matrix mineralization of chick
hypertrophic chondrocytes (Yagami et al., 1999). These re-
sults again suggest that the inhibition of mineralization by
MGP is Gla residue–dependent, but that the cell survival
properties conferred by MGP are not. Our results with the
MGP antiserum in the hypertrophic ATDC5 cells are at
variance with the cultures where MGP was inhibited by an-
tisense MGP mRNA, which might reflect differences either
in the accessibility, efficacy, or specificity of the antibody at
this stage of culture as compared with the antisense MGP.
 
Inducible overexpression of MGP prevents 
chondrocyte maturation and inhibits mineralization
 
Previously, virally driven overexpression of MGP in chick
limb buds has been demonstrated to cause severe alterations
of limb skeletogenesis with disruption of chondrocyte matu-
ration to hypertrophy (Yagami et al., 1999). In our stud-
ies, overexpression of MGP had no appreciable effect on
early ATDC5 differentiation, allowing cellular condensation,
chondrocyte proliferation, and cartilage nodule formation.
However, corresponding to the stage when MGP levels de-
creased in noninduced cultures (at day 21), overexpression
of MGP caused the cells to apoptose and detach. This sug-
gests that the decrease in MGP levels that occurs in the ma-
turing zone of the growth plate is vital to allow chondrocyte
maturation and subsequent hypertrophy, and a failure in
this modulation of expression disrupts this process. The
lower levels of type X collagen in cells overexpressing MGP
supports the suggestion that overexpression of MGP at this
stage inhibits further chondrocyte differentiation. Overex-
pression of MGP has been found in association with apopto-
sis in rat glial cells stimulated with 1, 25-dihydroxyvitamin
D3 (Baudet et al., 1998) and in the rat ventral prostate after
androgen withdrawal (Briehl and Miesfeld, 1991). A fall in
the transcription of MGP in serum-starved NIH3T3 cells
suggested that the increase in MGP expression associated
with apoptosis was not due to growth arrest (Briehl and
Miesfeld, 1991). Our results suggest that this increase in
MGP expression in association with apoptosis is more than a
bystander effect and that MGP is able to stimulate apoptotic
pathways either directly or in combination with other factors.
When the bone morphogenetic proteins (BMPs) were first
isolated, they were found to be in tight association with
MGP (Urist et al., 1984). MGP has been characterized as a
binding protein for BMP-2 (Wallin et al., 2000) and a recent
report suggests that MGP modulates BMP-2 activity (Bos-
tröm et al., 2001). BMP-2 has been characterized as an
activator of apoptosis via the TAK1-p38 kinase pathway
(Kimura et al., 2000), and it may well be that alterations of
MGP levels at critical points in the endochondral pathway al-
ter the interaction with BMP-2 and therefore affect apopto-
sis. This proposition will require further investigation. Over-
expression in later stage differentiating ATDC5 cells caused a
reduction in matrix mineralization consistent with previous
experiments where virally induced overexpression of MGP in
chick hypertrophic chondrocytes had a similar effect (Yagami
et al., 1999). This confirms that MGP has a cell-specific
function as an inhibitor of matrix mineralization.
Our results indicate that coordinated expression of MGP is
critical for chondrocyte survival in ATDC5 cells, as inhibiting
MGP expression during stages when it is normally expressed
and overexpressing it when it is normally not expressed cause
chondrocyte apoptosis. These findings imply that the bi-
phasic expression pattern of MGP within the mammalian
growth plate is required for normal chondrocyte differentiation
within the growth plate. That excessive MGP should have the
same effect as insufficient MGP at different stages in chondro-
cyte differentiation is intriguing. The mechanisms whereby
MGP modules these effects remain to be elucidated.
 
Materials and methods
 
Cell culture
 
ATDC5 cells were a gift from Dr. A. Grigoriadis (King’s College, London,
UK) and were maintained as described previously (Atsumi et al., 1990).
Figure 9. Calcium levels in ATDC5 cells overexpressing MGP. 
Calcium measurement in ATDC5 cell cultures transfected with 
pINDE/X on day 42. Cultures were induced with 5  M ponasterone 
A from day 21 onwards or not induced as controls. 
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Cells were cultured in a standard medium of DME/Hams’ F12 (1:1) con-
taining 5% FBS, 2 mM 
 
L
 
-glutamine, 50 U/ml penicillin, 50 
 
 
 
g/ml strepto-
mycin (all GIBCO BRL), and 10 
 
 
 
g/ml human transferrin, 10 
 
 
 
g/ml bovine
insulin, and 3 
 
 
 
 10
 
-8 
 
M sodium selenite (all Sigma-Aldrich) at standard
conditions (37
 
 
 
C in a humidified atmosphere of 5% CO
 
2 
 
in air). Cells were
plated in 6-well plates at a density of 6 
 
 
 
 10
 
4
 
 cells/well (day 0). Cells were
grown continuously in standard medium, which was replaced on alternate
days. After 21 d of culture, the medium was converted to 
 
 
 
MEM (GIBCO
BRL) with the same supplements and the CO
 
2
 
 level was lowered to 3%.
Integrity of cultures was confirmed by phase contrast microscopy.
Chondrogenesis was confirmed by fixing cells in 95% methanol and stain-
ing with in 0.5% alcian blue, pH 0.75 (Fluka), at various time points. To
determine cell proliferation, cells were trypsinized and counted on a
haemocytometer at fixed time points until day 15, when cells could not be
completely disassociated by trypsinization.
 
Northern blot analysis
 
RNA was extracted from the ATDC5 cells at different time points by a previ-
ously described method (Chomczynski and Sacchi, 1987). Samples of total
RNA (20 
 
 
 
g) were separated by electrophoresis on a 1% (wt/vol) agarose
formaldehyde gel and transferred to nitrocellulose filters by vacuum blotting
and baked in a vacuum oven at 80
 
 
 
C for 2 h. The filter was hybridized with
radio-labeled cDNA inserts at 68
 
 
 
C in solution containing 1% (wt/vol) BSA,
7% (wt/vol) SDS, and 0.125
 
 
 
 high salt buffer (1
 
 
 
 high salt buffer contains
2 M NaCl, 1 M HNa
 
2
 
O
 
4
 
P, and 0.14 M H
 
3
 
PO
 
4
 
) washed, exposed, and devel-
oped using standard conditions (Sambrook et al., 1989). Hybridization
cDNA probes were made by the random-primer method using the Oligo-
labeling kit (Amersham Pharmacia Biotech) using a 0.4-kb EcoR1-Xba1 frag-
ment of pMGPcJ (clone was a gift from Professor G. Karsenty, Baylor College
of Medicine, Houston, TX) (Luo et al., 1995) for mouse MGP; a 0.3-kb Xho1
fragment of IMAGE clone 1969710 (HGMP Resource Centre, Cambridge,
UK) for mouse type X collagen; a 1.3-kb Not1-Sal1 fragment of IMAGE
clone 613911 for mouse type II collagen; a 0.45-kb Not1-EcoR1 fragment of
IMAGE clone 472468 for mouse osteocalcin; and a 1.5-kb Not1-Sal1 frag-
ment of IMAGE clone 3156074 for mouse cytoplasmic 
 
 
 
-actin.
 
Antibody inhibition studies
 
ATDC5 cells were plated at 6 
 
 
 
 10
 
4
 
 cells/9.4 cm
 
2
 
 well in 6-well plates and
grown in standard medium. To each well of six 6-well plates on day 3, fil-
ter-sterilized MGP antiserum at 1:200 dilution was added and at each me-
dium change thereafter. The MGP antiserum used was rabbit antiserum
against a synthetic peptide of the COOH-terminal sequence (ERYAMVYG-
YNAAYNRYFRQRRGAKY) of mouse MGP (donated by Professor G. Karsenty,
Baylor College of Medicine, Houston, TX). To three separate 6-well plates,
MGP antiserum was added from day 21 and at each medium change there-
after. As controls, ATDC5 cell cultures were grown concurrently with no
antibody supplements and with filter-sterilized normal rabbit serum (Sigma-
Aldrich) at a 1:200 dilution added at the same time points as the MGP antise-
rum. These experiments were performed on at least three separate occasions.
 
Construction of sense and antisense
MGP-inducible expression vectors
 
The ecdysone-inducible mammalian expression system (Invitrogen) relies
on the constitutive expression of a heterodimeric ecdysone receptor from
 
Drosophila 
 
by the regulator vector pVgRXR. The ecdysone-responsive pro-
moter is located in a second vector, pIND, containing the gene of interest.
In the presence of the inducer, ponasterone A (Invitrogen), the functional
ecdysone receptor binds to the promoter and activates gene expression.
A 398-bp cDNA fragment of mouse MGP was excised from pMGPcJ us-
ing EcoR1 and Xba1 and directionally cloned into the EcoR1 and Xba1
sites in the multiple cloning site of pIND. The MGP cDNA in this construct
(pINDE/X) is in the sense orientation with regard to the upstream promoter.
For the antisense construct (pINDE/B), the MGP cDNA was excised from
pMGPcJ using EcoR1 and BamH1 and directionally cloned into the EcoR1
and BamH1 sites of the multiple cloning site of the pIND vector. The ori-
entation and sequence fidelity of the clones were checked by restriction
enzyme digest reactions, generating 416- and 428-bp fragments for MGP
cDNA within pINDE/B and pINDE/X, respectively, and DNA sequencing
using Big Dye terminator cycle sequencing reactions and analysis on an
ABI PRISM 377 DNA Sequencer (PerkinElmer).
 
Transfection and selection of stable cell lines
 
Dual transfections with pVgRXR and the respective pIND constructs were
performed using FuGENE 6 (Roche Molecular Biochemicals) according to the
manufacturer’s instructions. After transfection, cells were maintained in stan-
 
dard medium minus the ITS, but containing Zeocin™ (400 
 
 
 
g/ml of medium;
Invitrogen) and G418 (300 
 
 
 
g/ml of medium; Sigma-Aldrich). Antibiotic-
resistant clones transfected with either pINDE/X or pINDE/B were selected af-
ter 14 d by ring cloning (McFarland, 2000). The clones were expanded in
standard medium, including ITS, Zeocin, and G418. To confirm that the plas-
mid constructs affected over- and underexpression of MGP in the clones an
aliquot of cells from each clone was induced with 5 
 
 
 
M ponasterone for 48 h
after confluence. Both total RNA and protein were extracted from induced
and noninduced control cultures, and RT-PCR analysis and Western blotting
were performed as described. Stably transfected clones were plated at 6 
 
 
 
10
 
4
 
 cells/well in 6-well plates and grown in standard medium with Zeocin
and G418 supplementation. Nine concurrent cultures were induced with 5
 
 
 
M ponasterone at days 3, 12, and 21, with the addition of the inducing
agent at each medium change thereafter. Noninduced, transfected cells were
grown in parallel as controls. In addition, 5 
 
 
 
M of ponasterone was added to
normal ATDC5 cells from day 3 to 42 as a control. All cell culture experi-
ments were performed on a minimum of three occasions.
 
Reverse transcriptase (RT)-PCR
 
Mouse MGP transcripts were amplified by RT-PCR to confirm over- and un-
derexpression of MGP in the transfected cell lines. Total RNA was treated
with 5 
 
 
 
g DNase 1 and incubated at 37
 
 
 
C for 1 h. The RNA (1 
 
 
 
g) was re-
verse transcribed using
 
 
 
0.5 
 
 
 
g oligo (dT)
 
15
 
,
 
 
 
5 mM dNTPs (Sigma-Aldrich),
40 U RNAse inhibitor, 25 U AMV reverse transcriptase, and 1.25  reverse
transcriptase buffer (all Roche Molecular Biochemicals) at 42 C for 1 h and
at 90 C for 3 min. Amplification of 1/10 of the cDNA reaction was carried
out with 15 pmol primers, 0.1 mM each of dATP, dCTP, dGTP, dTTP, 5 U
Taq polymerase, 1  Taq polymerase buffer (Roche Molecular Biochemi-
cals). The following cycling conditions were used: to denature, 96 C for
60 s; to anneal, 59 C for MGP primers and 58 C for  -actin primers for 90 s;
and 72 C for 60 s for 23 or 35 cycles on a DNA Thermal Cycler (Cetus 480;
PerkinElmer). The sequences of primers for mouse MGP cDNA were (mgpF)
5 -ATGAAGAGCCTGCTCCCTCT-3  and (mgpR) 5 -ATATTTGGCTCCTCG-
GCGCT-3  generating a 312-bp fragment (Ikeda et al., 1991). To confirm in-
ducible expression from the pINDE/X construct, the ecdysone forward
primer sequence 5 -CTCTGAATACTTTCAACAAGTTAC-3  and primer
mgpR were used to generate a 450-bp fragment. For the pINDE/B construct
with the ecdysone, forward and mgpF primers were used to generate a 471-
bp fragment. The sequences of mouse cytoplasmic  -actin primers were 5 -
GAAGGCGACAGCAGTTGGTT-3   and 5 -ACGCGACCATCCTCCTCTTA-
3 , generating a 204-bp fragment (Tokunaga et al., 1986).
Real time PCR
Mouse MGP transcripts were amplified by real time PCR to establish the
levels of over- and underexpression of MGP in the transfected cell lines.
Total RNA was extracted using TRIZOL (GIBCO BRL) and treated with
DNase 1 at 37 C for 30 min. The RNA (2  g) was reverse transcribed using
the Taqman Gold RT-PCR kit according to the manufacturer’s instructions:
2.5  M oligo (dT)16, 500  M (of each) dNTPs, 0.5 U/ l RNase inhibitor,
1.25 U/ l MultiScribe reverse transcriptase, 1  TaqMan reverse tran-
scriptase buffer at 25 C for 10 min, 48 C for 20 min and 95 C for 5 min (PE
Biosystems). Amplification of 1/30 of the cDNA reaction was carried out
using the SYBR green PCR method according to manufacturer’s instruc-
tions (PE Biosystems). In brief, 1  SYBR green master mix, 300 nM for-
ward primer and 300 nM reverse primer and the cDNA were heated at
95 C for 10 min. The following cycling conditions were used: 95 C for 15 s
60 C for 1 min for 40 cycles on the PE-ABI 7700 sequence detector.
cDNAs were amplified using the following primers: ColII F, 5 -GGTGGCT-
TCCACTTCAGCTAT-3 ; ColII R, 5 -TCATTGGAGCCCTGGATGAG-3 ;
ColX F, 5 -TTCTCCTACCACGTGCATGTG-3 ; ColX R, 5 -AGGC-
CGTTTGATTCTGCATT-3 ; MgpF, 5 -CCTGTGCTACGAATCTCACGAA-
3 ; MgpR: 5 -TCGCAGGCCTCTCTGTTGAT-3 ;   -actin F, 5 -GAAGGC-
GACAGCAGTTGGTT-3 ;  -actin R, 5 -ACGCGACCATCCTCCTCTTA-3 ;
Bcl-2 F, 5 -TGTGTGTGGAGAGCGTCAACA-3 ; Bcl-2 R, 5 -CCAGGTAT-
GCACCCAGAGTGAT-3 ; Bax F, 5 -AGCTGCAGAGGATGATTGCT-3 ;
Bax R, 5 -GATCAGCTCGGGCACTTTAG-3 . All quantitations were nor-
malized to  -actin as an endogenous control and relative to a calibrator.
All real time PCR experiments were performed four times. Statistical analy-
sis was performed using a two-tailed Student’s t test.
Western blotting
Protein was extracted from ATDC5 cell cultures by the direct addition of
1  SDS sample buffer (0.5% [wt/vol] SDS, 2.5% [vol/vol] glycerol, 15.6
mM Tris-HCl, pH 6.8, 0.125% [vol/vol] bromophenol blue, 0.5% [vol/vol]
 -mercaptoethanol). Protein was separated by 15% (wt/vol) SDS-PAGE666 The Journal of Cell Biology | Volume 154, 2001
(Laemmli, 1970) alongside standard color markers. The gel was electro-
blotted to nitrocellulose in Towbin transfer buffer (Towbin et al., 1979).
Equal and efficient transfer of protein was confirmed by staining the nitro-
cellulose with Ponceau S (0.2% [wt/vol] Ponceau S/3% [vol/vol] trifluoro-
acetic acid). The MGP antiserum at 1:200 was used as primary antibody
and incubated overnight at 4 C. A biotinylated swine anti–rabbit second-
ary antibody (Dako) was used at 1:3,000 dilution and incubated for 30 min
at room temperature. The chemiluminescence (ECL
) detection system was
used to visualize the result (Amersham Pharmacia Biotech).
Measurement of precipitated in vitro calcium
To determine the level of matrix mineralization, cultures were washed in
PBS Dulbecco’s (GIBCO BRL), fixed in 50–100% methanol, and stained
with 1% (wt/vol) alizarin red, pH 4.2 (Fluka).
Separate cell cultures were decalcified by overnight incubation in 0.6 N
HCl. The calcium content of the HCl supernatant was determined colori-
metrically by the o-cresolphthalein complexone method (Sigma-Aldrich;
Mori et al., 1998). Statistical analysis of calcium levels was performed us-
ing a two-tailed Student’s t test.
Apoptosis
Markers of apoptosis were determined in two ways. Bcl-2 and Bax levels
were established at various time points by real time PCR as described above.
Secondly, nuclear morphology of the ATDC5 cells was examined by
fixing the chondrocytes in 1% (vol/vol) formaldehyde. The cells were
stained with 0.5  g/ml Hoechst 33258 and then visualized by fluores-
cence microscopy (Pullan et al., 1996).
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